Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Proven Results with advanced therapies and personalized care
Triple-hormone activation addresses multiple metabolic pathways to deliver weight reduction that matches surgical options
NOT FOR HUMAN OR VETERINARY USE
Note: Semaglutide carries an FDA boxed warning about the risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
These actions contribute to increased satiety, reduced appetite, and improved glucose control
While weight is an important factor, its just one piece of a larger picture
US$ 20.92
US$ 28.14
US$ 24.25
US$ 27.39
US$ 26.04
US$ 26.71
